United States · FDA National Drug Code directory
epoprostenol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62756-060_fae129b5-c1b5-45f2-864c-eee72f289334
- Product NDC
- 62756-060
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- epoprostenol
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210116
- Source listing expiry
- 20261231
Source-listed ingredients
- EPOPROSTENOL SODIUM — 1.5 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (62756-060-40) / 10 mL in 1 VIAL · 62756-060-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →